Managing Semaglutide Side Effects: Complete Guide

Quick Answer: Side effects vary by product, dose and person. The table below describes specific adult Wegovy injection trials; it does not predict your symptom severity or recovery time. Severe or persistent symptoms need assessment. Follow the urgent-care instructions below and your exact medication guide. Compounded semaglutide is not FDA-approved, and the trial figures below do not describe compounded preparations.

Important Disclaimer: Compounded semaglutide is NOT FDA-approved. The FDA does not verify the safety or effectiveness of compounded medications before marketing; the studies summarized here do not establish outcomes for compounded preparations. The frequencies below describe adult trials of Wegovy 2.4 mg injection, not all semaglutide preparations. This article is for educational purposes only and is not medical advice. Follow your prescription for routine treatment decisions. Urgent symptoms are an exception: follow the stop-and-seek-care instructions in your medication guide and the warning section below.

Starting semaglutide for weight loss is a significant step, and knowing what to expect and how to respond to potential side effects can make the experience smoother. Understanding how your body may respond—and what to do about it—can help, but no medication is risk-free and individual experiences differ. This guide covers common digestive issues through rare but serious concerns. Always follow your prescribing clinician’s instructions; do not self-adjust your dose.

Most Common Side Effects (And What Causes Them)

Semaglutide activates GLP-1 receptors involved in appetite regulation. Gastrointestinal reactions are reported in the trials below; those frequency data do not establish one mechanism for every symptom. Wegovy labeling, sections 6.1 and 12.1.

Gastrointestinal Side Effects (Most Frequent)

Wegovy labeling, section 6.1, Table 3, reports these pooled adult weight-management results from three trials lasting up to 68 weeks, with seven weeks of off-drug follow-up:

Reported reaction	Wegovy 2.4 mg injection (n=2,116)	Placebo (n=1,261)
Nausea	44%	16%
Diarrhea	30%	16%
Constipation	24%	11%
Vomiting	24%	6%
Abdominal pain (grouped terms)	20%	10%
Abdominal distension	7%	5%
Flatulence	6%	4%

These are pooled results, not STEP 1 alone. Abdominal pain includes several related pain/discomfort terms. The table does not establish symptom duration or rates for tablets, other doses, children or compounded preparations.

Why symptoms need assessment: A symptom during treatment is not automatically explained by delayed digestion or temporary adjustment. Discuss persistent symptoms and other possible causes with your clinician.

Understanding your semaglutide weight loss timeline helps set realistic expectations for both results and side effects during different phases of treatment.

Other Common Side Effects

The same table reports headache in 14% versus 10%, fatigue (including asthenia) in 11% versus 5%, and dizziness in 8% versus 4% for Wegovy versus placebo. It does not establish that these effects are confined to the first weeks or caused by eating changes.

For comprehensive information on how semaglutide works and its overall benefits, see our complete guide to semaglutide.

Side Effects Timeline: What to Expect Week by Week

A dose-escalation schedule is not a symptom calendar. The frequency table above does not predict how many days nausea will last after a dose or a week when side effects will disappear.

Your prescriber sets the schedule for your exact product and response. Do not treat week nine as a universal maintenance milestone or change dose timing to fit a symptom forecast. Report severe or persistent symptoms promptly; routine progress checks do not replace urgent assessment.

Managing Nausea: The #1 Side Effect

Nausea is the most commonly reported side effect. Some people find the strategies below help; severe or persistent nausea needs a clinician.

Dietary Strategies

For mild nausea, MedlinePlus guidance suggests smaller meals, bland foods such as toast or rice, avoiding strong food odors and remaining upright after eating. This is general nausea advice, not a trial of semaglutide symptom treatment.

Hydration Tips

Discuss suitable fluids and amounts with your care team, especially if you have a fluid restriction. Contact your provider if you cannot keep food or liquids down; do not wait 24 hours before seeking advice. Follow the urgent-symptom instructions below.

Timing Strategies

Follow the administration instructions for your exact product. Report symptoms to your prescriber instead of changing dose timing or escalation yourself.

Over-the-Counter Remedies

Ask your clinician or pharmacist before adding a supplement or medicine for nausea. A remedy used for another cause of nausea is not automatically appropriate for semaglutide-related symptoms. Persistent symptoms may require assessment and a prescription treatment chosen for your situation.

Managing Other Digestive Issues

These are general digestive-care measures. They do not establish a treatment protocol for every semaglutide preparation or replace evaluation of severe or persistent symptoms.

Diarrhea Management

NIDDK guidance emphasizes replacing lost fluids and electrolytes. People with diabetes, kidney disease or other health conditions should ask about suitable rehydration fluids and amounts. Many people can resume their usual diet when appetite returns; a restrictive BRAT diet is not automatically required.

Tell your clinician about persistent or worsening diarrhea. If it worsens or lasts more than two days while taking an over-the-counter diarrhea medicine, NIDDK advises seeing a doctor. Do not wait two weeks to seek advice, and do not use self-care to delay urgent assessment.

Constipation Management

NIDDK guidance describes dietary fiber, adequate fluids and regular activity as options that may help. Discuss changes suited to your health and mobility. Ask which laxative or fiber supplement, if any, is appropriate and for how long; this article does not prescribe a stool softener or a fixed daily water target.

Bloating and Gas

NIDDK guidance suggests eating more slowly and avoiding fizzy drinks to reduce swallowed air. Discuss food triggers and possible underlying causes with your clinician. Medicine or supplement selection depends on the cause; this does not support routine digestive enzymes or peppermint oil for everyone taking semaglutide.

Managing Injection Site Reactions

Wegovy labeling, section 6.1, reports injection-site reactions in 1.4% of treated adults versus 1% receiving placebo in weight-reduction trials. This does not compare semaglutide with other injectable medicines or establish rates for compounded products.

Prevention Tips:

Use the instructions for your exact device. Wegovy’s pen instructions say to change the injection spot, avoid tender, bruised, red, hard or scarred skin, and let cleaned skin dry. Ask your pharmacist to demonstrate your device; injection speed, preparation and handling are not universal across pens and syringes.

Some patients prefer oral semaglutide to avoid injections entirely. Both injectable and oral forms are available depending on your preferences.

Rare But Serious Side Effects (When to Call Your Doctor)

While uncommon, these require immediate medical attention:

Boxed Warning: Thyroid C-Cell Tumors

FDA-approved semaglutide carries a Boxed Warning—the FDA’s strongest warning—because, in rodent studies, semaglutide caused thyroid C-cell tumors. It is not known whether semaglutide causes such tumors, including medullary thyroid carcinoma (MTC), in humans. Do not use semaglutide if you or a family member has had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician right away about any neck lump or swelling, hoarseness, trouble swallowing, or shortness of breath. This warning is not something that can be “managed away.”

Pancreatitis Warning Signs

• Severe, persistent abdominal pain (upper left or middle abdomen)
• Pain radiating to your back
• Nausea and vomiting that won’t stop
• Fever

Action: Wegovy’s Medication Guide directs stopping Wegovy and contacting your healthcare provider right away for severe abdominal pain that persists, with or without nausea or vomiting. Pain may extend to the back. Do not wait for every symptom listed here to occur. Follow the instructions for your exact medication.

Gallbladder Problems

• Severe upper right abdominal pain
• Yellowing of skin or eyes (jaundice)
• Clay-colored stools
• Pain after eating fatty meals

Action: Contact your doctor promptly. Rapid weight loss can increase gallstone risk.

Kidney Problems

• Decreased urination
• Swelling in legs/feet
• Persistent diarrhea or vomiting leading to dehydration
• Unusual fatigue

Action: Tell your healthcare provider right away about nausea, vomiting or diarrhea that does not go away. Dehydration can lead to kidney problems; severe or persistent symptoms should not wait for a routine appointment. Wegovy Medication Guide.

Hypoglycemia (Low Blood Sugar)

More common if taking diabetes medications alongside semaglutide:

• Shakiness, sweating, confusion
• Rapid heartbeat
• Dizziness or lightheadedness
• Extreme hunger

Action: Follow your agreed low-glucose treatment plan. NIDDK guidance advises checking glucose when symptoms occur. If you can safely swallow and glucose is below your target or 70 mg/dL, take 15–20 grams of glucose or fast-acting carbohydrate, recheck after 15 minutes, and repeat if still low. Severe episodes require help: for unconsciousness, seizures or inability to treat yourself, someone should call 911 and use prescribed glucagon as instructed. Do not give food or drink to an unconscious person. Review episodes and medication adjustments with your clinician.

Allergic Reactions

Possible signs of a serious allergic reaction include:

• Severe rash or hives
• Swelling of face, lips, tongue, or throat
• Difficulty breathing
• Rapid heartbeat

Action: Stop using Wegovy and get medical help right away for signs of a serious allergic reaction. Call 911 for trouble breathing or throat swelling. Follow your exact product’s instructions. Wegovy Medication Guide.

Who Tends to Experience Worse Side Effects?

Risk assessment should consider your health history, medicines and exact product. Wegovy labeling does not recommend use in severe gastroparesis and calls for kidney-function monitoring when adverse effects could cause dehydration. Tell your clinician about digestive conditions and previous reactions before starting treatment.

A history of tolerating medicines or changing your diet does not guarantee mild side effects. Report symptoms on their own merits; this article does not establish a sex-, hormone- or anxiety-based risk ranking.

For information on compounded semaglutide quality and safety, see our guide on compounded semaglutide safety.

Medication Interactions to Watch

Semaglutide can interact with other medications:

Diabetes Medications

Wegovy labeling, section 7.1, identifies increased hypoglycemia risk with insulin or insulin-releasing medicines such as sulfonylureas. Your clinician may need to adjust those medicines. Do not change doses yourself.

Oral Medications Generally

Section 7.2 calls for monitoring oral medicines’ effects and considering closer clinical or laboratory checks when appropriate. It does not give a universal spacing rule around injections. Semaglutide tablets have separate administration instructions. Review your full medication list with your prescriber or pharmacist.

Always Tell Your Doctor About:

• All prescription medications
• Over-the-counter supplements
• Herbal remedies
• Recent medication changes

When to Talk to Your Clinician About Your Dose

Any change to your dose or schedule is a decision for your prescribing clinician—do not adjust it yourself. Contact your clinician promptly if:

Reach Out to Your Clinician If:

• Nausea interferes with eating or drinking; do not wait three days to report severe or persistent symptoms
• Weight is dropping faster than your clinician expected
• Side effects significantly impact work or daily activities
• You’re struggling to stay hydrated due to nausea/vomiting
• You have questions about your progress at your current dose

Your Clinician May Discuss Options Such As:

Wegovy labeling, sections 2.2–2.3, allows delaying escalation when a dose is not tolerated; injection and tablet instructions differ. Your prescriber should assess symptoms and the exact product before deciding whether to change treatment. Severe symptoms may require urgent action rather than a lower dose.

Ask about appropriate symptom treatment or alternatives, including the evidence discussed in our tirzepatide comparison. This is not a recommendation to use unlisted intermediate doses or a particular anti-nausea medicine.

Remember: There’s no prize for getting to a maximum dose quickly, and you should never change your own dose. Your clinician determines what’s right for you.

Cost Considerations for Side Effect Management

Factor these potential additional costs into your budget:

• Anti-nausea medication: $10-50/month if needed
• Probiotics: $15-30/month
• Fiber supplements: $10-20/month
• Ginger: $10-15/month
• Vitamin B6: $5-10/month

Most patients don’t need all of these, but budget $20-50/month for symptom management supplies. This is in addition to the cost of semaglutide itself.

Long-Term Side Effects and Maintenance

There is no universal month when digestive symptoms or fatigue must resolve. Persistent or new symptoms need assessment rather than being attributed automatically to adjustment, food choices or weight loss. Review your response and ongoing care needs with your prescriber.

Stopping Semaglutide

Discuss planned discontinuation with your clinician. Urgent stop-and-seek-care instructions take priority over routine planning.

The STEP 1 extension followed a subset of adults without diabetes after 68 weeks of semaglutide 2.4 mg injection or placebo. Medication and the study lifestyle intervention both stopped. Among 327 participants in the extension analysis, the former semaglutide group regained roughly two-thirds of its prior weight loss over the following year, on average.

This exploratory follow-up does not establish a personal appetite or side-effect recovery timeline, prove that regain reflects insufficient effort, or test compounded preparations. See our stopping semaglutide guide for questions to discuss with your care team.

Making Semaglutide Work for You

The key to success with semaglutide is being proactive about side effect management:

Before Starting:

1. Stock your kitchen with bland, easy-to-digest foods
2. Confirm how to reach your care team if symptoms occur
3. Discuss suitable food and hydration options with your care team
4. Mentally prepare for appetite changes

During Treatment:

1. Start dietary changes immediately, don’t wait for problems
2. Keep a symptom journal to track patterns
3. Communicate openly with your medical provider
4. Join online support communities for tips and encouragement
5. Remember side effects often ease over time for many people but vary — talk to your clinician

Partnership with Your Provider:

At Boca Health, our medical team provides ongoing support for side effect management. You’ll have access to:

• Unlimited messaging with medical staff
• Dose adjustment guidance based on your tolerance
• Prescription anti-nausea medication if needed
• Nutrition guidance for symptom management
• Support throughout your entire weight loss journey

The Bottom Line

Side effects from semaglutide are common. For many people they are mild to moderate and ease over time, but they are not guaranteed to be mild for everyone, and some people experience serious effects. No medication is risk-free. Understanding what to expect, using supportive dietary strategies, and working closely with your licensed clinician—rather than self-adjusting your dose—can help you respond appropriately.

The trial findings above apply to the preparations studied. Compounded medicines are not FDA-approved, and these studies do not establish their safety or effectiveness. Absence of FDA approval is not a claim that no research exists.

Considering treatment with comprehensive medical support? Explore our semaglutide program, which includes side-effect support and ongoing clinician guidance. Compounded semaglutide is not FDA-approved.

Related reading: For the evidence limits around lower-dose approaches, read Microdosing Semaglutide: The Honest Guide to Low-Dose, Personalized GLP-1 Care.